|

Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects

RECRUITINGSponsored by Mayo Clinic
Actively Recruiting
SponsorMayo Clinic
Started2016-11-18
Est. completion2026-11-18
Eligibility
Age40 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06536452

Summary

This study evaluates hematopoiesis to determine how MBL/CLL affected bone marrow responds to fight off infections in the body.

Eligibility

Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria:

* Subjects in the CLL cohort who are eligible for these studies will have a clinically established diagnosis of CLL as assessed by flow cytometry and will include subjects who

  * Remain untreated
  * Are currently being treated
  * Who have already been treated
* Subjects in the MBL cohort will have a clinically established diagnosis of MBL
* Healthy age-matched control subjects
* Healthy younger control subjects aged \> 40 years

Exclusion Criteria:

* Anyone under 40
* Healthy control subjects must not have a diagnosis of CLL or MBL

Conditions3

CancerChronic Lymphocytic LeukemiaMonoclonal B-Cell Lymphocytosis

Locations1 site

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
Clinical Trials Referral Office855-776-0015mayocliniccancerstudies@mayo.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.